VP-GL is a synthetic phosphodiesterase inhibitor formulated for topical application. It is used to enhance local microcirculation in peripheral vascular disorders. The active compound penetrates the stratum corneum and binds to pde enzymes in endothelial cells. Inhibition of pde leads to increased cyclic amp levels within vascular smooth muscle. Elevated cyclic amp promotes relaxation of vascular tone and facilitates nitric oxide release. The resulting vasodilation improves blood flow and reduces ischemic symptoms. Pharmacodynamically the drug's effect is dose-dependent and reversible. Its mechanism relies on selective blockade of phosphodiesterase activity to modulate vascular signaling.

VP-GL is a pharmacologically active compound developed to modulate selective pathways in cellular signaling. It is classified as a synthetic antagonist that targets specific receptor subunits involved in inflammatory responses. The therapeutic role of VP-GL centers on reducing excessive immune activation observed in certain autoimmune conditions. Its mode of action involves binding to intracellular protein kinases and inhibiting downstream transcriptional events that drive cytokine production. By dampening these signaling cascades VP-GL helps restore homeostasis in affected tissue compartments. The net effect is a controlled attenuation of inflammatory signaling without broad immunosuppression.

VP-GL may cause mild headache in some users. It can occasionally lead to nausea. Some individuals experience temporary dizziness. Flushing of the skin has been reported. Mild stomach discomfort may occur. Fatigue can be experienced intermittently. Transient changes in taste perception are possible.

VP-GL may cause mild headache in some users. It can lead to temporary facial flushing due to blood vessel dilation. Some individuals report mild nausea or stomach discomfort after taking it. Dizziness or light-headedness can occur, especially when standing up quickly. Occasional insomnia or changes in sleep patterns have been noted. A small number of users experience mild muscle aches or joint stiffness. Skin reactions such as itching or rash may appear in sensitive individuals. These effects are generally short-lived and resolve without specific treatment.